You are here

FDA warns researchers on claims of drug to detect brain disease

New York

THE developers of a new drug aimed at diagnosing chronic traumatic encephalopathy, the degenerative brain disease linked to repeated head trauma, are under scrutiny by the US Food and Drug Administration.

In February, the FDA's Office of Prescription Drug Promotion sent a...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes